ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.526,90
0,48%
S&P 500
5.187,70
0,13%
Dow Jones
38.884,26
0,08%
Euro vs US Dollar
1,07513
0,01%
Bitcoin
62.416,26
0,13%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Supernus Pharmaceuticals Inc (SUPN)

  7. Supernus Pharmaceuticals Inc (SUPN) News

SUPN Supernus Pharmaceuticals Inc

31,15
0,00 (0,00%)
Vor Marktöffnung
Zuletzt aktualisiert: 10:05:35
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Supernus Pharmaceuticals Inc SUPN NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,00 0,00% 31,15 10:05:35
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
31,15
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.5.202416:00PRNUSM8 Pharmaceuticals, an Acino company, signs an exclusive..
01.5.202414:00GLOBEBusy Philipps Shines Spotlight on ADHD in Women and Shares..
24.4.202422:05GLOBESupernus Pharmaceuticals to Announce First Quarter 2024..
08.4.202414:00GLOBESupernus Provides Regulatory Update for SPN-830
06.3.202422:30GLOBESupernus to Participate in Two Upcoming Investor Conferences
29.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.2.202423:00EDGAR2Form 8-K - Current report
28.2.202422:30GLOBESupernus to Participate in the TD Cowen 44th Annual..
27.2.202423:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27.2.202422:14EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27.2.202422:05GLOBESupernus Announces Fourth Quarter and Full Year 2023..
26.2.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.2.202422:27EDGAR2Form 144 - Report of proposed sale of securities
22.2.202423:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.2.202420:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202413:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13.2.202422:08EDGAR2Form 8-K - Current report
13.2.202422:05GLOBESupernus Pharmaceuticals to Announce Fourth Quarter and Full..
05.2.202415:21EDGAR2Form 8-K - Current report
05.2.202414:30GLOBESupernus Wins Infringement and Validity Case on Trokendi XR®..
12.1.202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10.1.202422:08EDGAR2Form 144 - Report of proposed sale of securities
26.12.202323:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202313:30GLOBEKnight Therapeutics Enters into Exclusive License Agreement..
18.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.12.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202311:50IHMARKETNEWSHasbro Job Cuts, Oracle’s Stock Decline, Google’s Epic..
17.11.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.11.202323:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.11.202322:22EDGAR2Form 144 - Report of proposed sale of securities
14.11.202320:59EDGAR2Form 144 - Report of proposed sale of securities
08.11.202322:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08.11.202322:10EDGAR2Form 8-K - Current report
08.11.202322:05GLOBESupernus Announces Third Quarter 2023 Financial Results
07.11.202322:30GLOBESupernus to Participate in the Jefferies London Healthcare..
02.11.202321:24EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht

NASDAQ
SUPN
Supernus Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten